These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23618698)

  • 1. Determination of the warfarin inhibition constant Ki for vitamin K 2,3-epoxide reductase complex subunit-1 (VKORC1) using an in vitro DTT-driven assay.
    Bevans CG; Krettler C; Reinhart C; Tran H; Koßmann K; Watzka M; Oldenburg J
    Biochim Biophys Acta; 2013 Aug; 1830(8):4202-10. PubMed ID: 23618698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.
    Fregin A; Czogalla KJ; Gansler J; Rost S; Taverna M; Watzka M; Bevans CG; Müller CR; Oldenburg J
    J Thromb Haemost; 2013 May; 11(5):872-80. PubMed ID: 23452238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tris(3-hydroxypropyl)phosphine is superior to dithiothreitol for in vitro assessment of vitamin K 2,3-epoxide reductase activity.
    Krettler C; Bevans CG; Reinhart C; Watzka M; Oldenburg J
    Anal Biochem; 2015 Apr; 474():89-94. PubMed ID: 25524619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling.
    Müller E; Keller A; Fregin A; Müller CR; Rost S
    BMC Genet; 2014 Feb; 15():17. PubMed ID: 24491178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.
    Czogalla KJ; Biswas A; Wendeln AC; Westhofen P; Müller CR; Watzka M; Oldenburg J
    Blood; 2013 Oct; 122(15):2743-50. PubMed ID: 23982176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
    J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two reducing agents dithiothreitol and tris(3-hydroxypropyl)phosphine for
    Takeda K; Morita A; Ikenaka Y; Nakayama SMM; Ishizuka M
    Vet Anim Sci; 2020 Jun; 9():100095. PubMed ID: 32734105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin resistance in a French strain of rats.
    Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
    J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.
    Oldenburg J; Bevans CG; Müller CR; Watzka M
    Antioxid Redox Signal; 2006; 8(3-4):347-53. PubMed ID: 16677080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.
    Harrington DJ; Underwood S; Morse C; Shearer MJ; Tuddenham EG; Mumford AD
    Thromb Haemost; 2005 Jan; 93(1):23-6. PubMed ID: 15630486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines.
    Jin DY; Tie JK; Stafford DW
    Biochemistry; 2007 Jun; 46(24):7279-83. PubMed ID: 17523679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of vitamin K epoxide reductase.
    Tie JK; Stafford DW
    Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
    Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
    Cain D; Hutson SM; Wallin R
    Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.